Pfizer asks hourly staffers to return overpayments in aftermath of vendor’s cyberattack: reports
Pfizer asks hourly staffers to return overpayments in aftermath of [...]
Pfizer asks hourly staffers to return overpayments in aftermath of [...]
Bristol Myers CEO Caforio takes pay cut as ‘human capital’ [...]
After pocketing $18.9M, Seagen’s Clay Siegall could reclaim spot among [...]
Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay [...]
Sanofi’s CDMO spinoff set for next month as new group [...]
Fierce Pharma Asia—FDA oncology czar on China PD-1 rebuff; US [...]
Gilead’s Kite flies higher as Yescarta leads CAR-T therapy class [...]
Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline [...]
Senate blesses bill to wrest US supply chains from China’s [...]
After FDA green lights a second COVID booster, official says [...]